Gap Cancer-401: Identify biomarkers for estimating individual susceptibility, risk assessment, and health monitoring.
This Gap was merged into the following Gap:
Cancer-202: Evaluate the contribution of genetic background/diversity on carcinogenesis risk.

Merge Rationale
No rationale available.